Wegovy in Northern Ireland: Availability, Eligibility and What You Need to Know

Wegovy has become one of the best known prescription treatments for weight management in the UK.

For people living in Northern Ireland, however, there can still be confusion about who may be suitable, whether Wegovy is available through the Health Service and how private treatment works.

There has also been an important recent development. Wegovy is no longer only available as an injection in the UK. A tablet form of Wegovy was approved in June 2026.

Here is what you need to know.

What Is Wegovy?

Wegovy is the brand name for a medicine containing semaglutide.

Semaglutide belongs to a group of medicines known as GLP 1 receptor agonists.

Wegovy is licensed for weight management alongside:

A reduced calorie diet Increased physical activity Wider lifestyle changes

It is a prescription only medicine, which means treatment should only be started following an appropriate clinical assessment.

How Does Wegovy Work?

Semaglutide works by acting on the GLP 1 hormone system.

GLP 1 is naturally produced in the body and is involved in appetite, digestion and blood glucose regulation.

For people using Wegovy for weight management, semaglutide can help to:

Reduce appetite Increase feelings of fullness after eating Reduce hunger between meals Help reduce overall food intake

It does not simply cause weight loss on its own.

Treatment is intended to be used alongside changes to nutrition, physical activity and other lifestyle factors.

Is Wegovy an Injection or a Tablet? Wegovy injection

Wegovy has traditionally been supplied as a once weekly injection.

Treatment normally begins at a low dose before being increased gradually, where clinically appropriate.

This gradual increase is intended to help the body adjust to treatment and reduce the likelihood of gastrointestinal side effects.

Wegovy tablets

In June 2026, the MHRA approved the first GLP 1 tablet specifically licensed for weight loss and weight management in the UK.

The tablets also contain semaglutide.

Unlike the injection, which is normally taken once each week, the tablet formulation is taken once daily.

The existence of different formulations does not mean that everyone can choose whichever version they prefer.

The appropriate treatment and formulation should be decided following clinical assessment.

Who May Be Suitable for Wegovy?

Under its UK licence, Wegovy may be considered for adults with:

A BMI of 30 or above, or A BMI between 27 and 30 where at least one weight related health condition is present

Weight related conditions can include:

High blood pressure Abnormal cholesterol or blood fats Prediabetes Type 2 diabetes Obstructive sleep apnoea Cardiovascular disease

However, meeting the BMI criteria does not automatically mean that Wegovy is suitable.

A prescriber will also need to consider your overall medical circumstances.

What Will a Prescriber Consider?

Before prescription weight management treatment is started, an appropriate assessment may consider:

Your current weight and BMI Your medical history Existing health conditions Current prescription medicines Previous weight management attempts Previous reactions to medicines Relevant gastrointestinal conditions Diabetes and blood glucose control Pregnancy or plans for pregnancy Other factors that could affect treatment safety

Further information may sometimes be required before a prescribing decision can be made.

Can You Get Wegovy on the Health Service in Northern Ireland?

Access to prescription weight management treatment through the Health Service in Northern Ireland has historically been limited.

That position is now beginning to change.

In June 2026, the Department of Health announced the first phase of Northern Ireland's new Regional Obesity Management Service.

The service has received £5 million in funding and is expected to begin rolling out in early autumn 2026.

The new service is intended to provide:

Specialist weight management support Lifestyle interventions Access to weight management medicines where clinically appropriate Treatment in line with NICE guidance

Importantly, the first phase will focus on people with the highest clinical need.

Does This Mean Everyone Can Get Wegovy From Their GP?

No.

The introduction of Northern Ireland's new obesity service does not mean Wegovy will immediately become routinely available to everyone who meets the basic licensed criteria.

Health Service access depends on factors including:

NICE recommendations Clinical eligibility Local treatment pathways Specialist service availability Individual medical circumstances The phased rollout of the new Northern Ireland service

Your GP may be able to discuss your weight and wider health with you, but access to specialist prescription weight management treatment may involve a dedicated pathway rather than routine GP prescribing.

What Does NICE Recommend for Wegovy?

NICE recommends semaglutide as an option for weight management within a specialist weight management service for certain adults.

The current NICE recommendation generally applies where someone has:

At least one weight related health condition, and A BMI of 35 or above

It may also apply to some people with a BMI between 30 and 34.9 who meet the criteria for referral to specialist weight management services.

Lower BMI thresholds may be appropriate for people from certain ethnic backgrounds because the health risks associated with excess weight can develop at a lower BMI.

Licensed criteria and Health Service criteria are different

This distinction is important.

The conditions under which a medicine is licensed for use in the UK are not necessarily the same as the criteria used to decide who receives that treatment through the Health Service.

Someone could therefore fall within the licensed indication for Wegovy without meeting the criteria for publicly funded treatment.

Can Wegovy Be Prescribed Privately in Northern Ireland?

Private treatment is a separate route from Health Service treatment.

A qualified prescriber can assess whether prescription weight management treatment may be appropriate for an individual.

Private treatment should still involve a genuine clinical assessment.

It should not simply involve selecting Wegovy from a website and purchasing it without appropriate medical review.

A private assessment may include: Weight and BMI verification Medical history Current medicines Relevant health conditions Previous treatment Potential medicine interactions Clinical risks Treatment expectations Ongoing monitoring requirements

Requesting Wegovy does not guarantee that it will be prescribed.

The prescribing decision remains with the clinician.

Will My GP Take Over My Wegovy Prescription?

You should not assume that your GP will take over prescribing if you begin treatment privately.

Private and Health Service prescribing arrangements are separate.

If you are considering private treatment, it is sensible to understand:

The initial consultation cost The cost of ongoing treatment Follow up arrangements How repeat prescriptions are managed What happens if your treatment needs to change What monitoring is included

Your normal GP should continue to manage your wider healthcare needs.

What Are the Common Side Effects of Wegovy?

The most frequently reported side effects of semaglutide involve the digestive system.

These can include:

Nausea Diarrhoea Constipation Vomiting Abdominal discomfort Indigestion Bloating

Headache and dizziness can also occur.

Side effects may be more noticeable when treatment begins or when the dose is increased.

Some people experience relatively mild symptoms, while others may find them more troublesome.

Why Is Hydration Important?

Nausea, vomiting and diarrhoea can lead to fluid loss.

This means people experiencing gastrointestinal side effects should be particularly conscious of staying adequately hydrated.

Significant dehydration can occasionally contribute to kidney problems, particularly in people who already have impaired kidney function.

Contact a healthcare professional if symptoms are severe, persistent or preventing you from keeping fluids down.

When Should You Seek Urgent Medical Advice?

GLP 1 medicines have been associated with uncommon but potentially serious complications.

Severe abdominal pain

Seek urgent medical attention if you experience persistent and severe abdominal pain, particularly if it travels towards your back or is accompanied by nausea or vomiting.

These can be symptoms of acute pancreatitis.

Sudden changes in vision

Semaglutide product information also contains warnings concerning a rare eye condition called non arteritic anterior ischaemic optic neuropathy, or NAION.

A sudden loss or significant deterioration of vision requires urgent medical assessment.

Severe allergic reaction

Symptoms such as difficulty breathing, swelling of the face or throat or a severe allergic reaction require immediate medical attention.

Wegovy and Pregnancy

Wegovy should not be used during pregnancy.

Semaglutide remains in the body for a considerable period of time.

Current product information advises that semaglutide should be stopped at least two months before a planned pregnancy.

If you become pregnant while using Wegovy, contact the healthcare professional responsible for your treatment.

Wegovy should also not be used while breastfeeding.

Does Wegovy Affect the Contraceptive Pill?

This is an area where Wegovy and Mounjaro are sometimes confused.

Semaglutide has not been shown to reduce exposure to the combined oral contraceptive medicines studied in the same way that specific contraceptive precautions are recommended with tirzepatide.

However, vomiting or severe diarrhoea can affect the reliability of oral contraception regardless of the medicine causing it.

If this happens, follow the missed pill or sickness guidance supplied with your contraceptive and seek professional advice if required.

Can You Buy Wegovy Online?

Yes, legitimate pharmacies and healthcare services can provide prescription treatment remotely.

However, Wegovy cannot legally be treated like an ordinary online retail product.

It must be supplied against a prescription issued following an appropriate clinical assessment.

Be cautious of medicines offered through:

Social media sellers Messaging apps Unregulated websites Online marketplaces People selling unused pens Sellers who do not require a proper clinical assessment

Medicines obtained through unauthorised sources may be counterfeit, incorrectly stored or unsafe.

Is Wegovy the Same as Ozempic?

No.

Both medicines contain semaglutide, but they are licensed and supplied for different purposes.

Wegovy is specifically licensed for weight management in eligible patients.

Ozempic is licensed for the treatment of type 2 diabetes.

They should not be treated as interchangeable products without medical advice.

Is Wegovy Better Than Other Weight Management Treatments?

There is no single treatment that is best for everyone.

The most appropriate option depends on factors including:

BMI Medical history Existing health conditions Other medicines Previous treatment Side effects Individual response Personal circumstances

Prescription decisions should therefore be made for the individual rather than simply choosing the most popular treatment.

What Happens If Wegovy Works?

Weight management should not be considered only in terms of how quickly the number on the scales changes.

A broader treatment plan may focus on:

Sustainable weight reduction Improving diet quality Maintaining muscle mass Eating adequate protein Increasing physical activity Improving sleep Reducing health risks Building habits that can be maintained Monitoring progress over time

Medication can support these changes for suitable patients, but it should form part of a wider weight management approach.

What Happens If Wegovy Does Not Work?

People respond differently to weight management medicines.

NICE currently recommends considering stopping semaglutide if a person has lost less than 5% of their initial body weight after six months of treatment.

Individual circumstances still matter, and decisions about continuing, changing or stopping treatment should be discussed with the clinician responsible for prescribing it.

Wegovy in Northern Ireland: Where Should You Start?

If you are considering prescription weight management treatment, the first step should be an appropriate health assessment rather than choosing a medicine.

Your GP may be a sensible starting point if:

You have unexplained weight gain You have significant existing health conditions You are experiencing symptoms that need investigation You want to explore Health Service support

Private weight management is another option for people who would like an individual assessment outside the Health Service.

Whichever route you choose, treatment should be based on your health, medical history and individual circumstances.

Weight Management Support From Keltoi Wellness

Keltoi Wellness provides a doctor led private weight management service for eligible adults in Northern Ireland.

The process begins with an individual health assessment.

Where prescription treatment is being considered, the doctor reviews the information provided and determines whether treatment is clinically appropriate.

Completing an assessment does not guarantee that Wegovy or any other prescription treatment will be suitable.

The final treatment decision remains with the prescribing clinician.

This article provides general information and does not replace individual medical advice. Wegovy is a prescription only medicine. Speak to an appropriately qualified healthcare professional before starting, changing or stopping prescription treatment.

Last updated: August 2026